Skip to main content
DGWPF logo

Drägerwerk AG & Co. KGaA (DGWPF) Stock Price & Analysis

Drägerwerk AG & Co. KGaA (DGWPF) — price $102.31 (0.00%), as of the Oct 5, 2026 trading session; market cap $1.92B.

Educational signal · not a buy or sell recommendation · How to read this

$102.31 $0.00 (0.00%) Market Cap $1.92B

Drägerwerk AG & Co. KGaA · DGWPF

Drägerwerk AG & Co. KGaA is a global medical and safety technology company, providing system solutions and devices for emergency medicine, intensive care, and personal protection. The company's diverse portfolio addresses critical needs in both healthcare and industrial safety sectors worldwide.

Price as of Oct 5, 2026

Key Statistics

No publishable V2 score is available for this stock yet.

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$102.31
Change on the day0.00%
52-week range$57.00 – $102.31
Market capitalisation$1.92B
Price / earnings (trailing)12.80
Shares traded on the day100

Price & events

Other perspectives

Council score for Drägerwerk AG & Co. KGaA (DGWPF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

9-Factor Breakdown

Revenue Growth Neutral
Gross Margin Strong
Operating Leverage Neutral
Cash Runway Strong
R&D Intensity Neutral
Insider Activity Moderate
Trading Liquidity Weak
Price Momentum Moderate
News Sentiment Neutral

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Neutral
Debt/Equity Moderate
ROE Neutral
Gross Margin Moderate

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Oct 5, 2026, except a card that shows its own read date.

Watch the DGWPF film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is Drägerwerk AG & Co. KGaA (DGWPF), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Drägerwerk AG & Co. KGaA (DGWPF) is the company analyzed here. It employs 16,687 people and is led by Stefan A. Drager. In Q2 FY2026 it reported revenue of $950M and net income of $32M. The market values it at $1.92B.

2 · Latest results

What do the latest results show for Drägerwerk AG & Co. KGaA (DGWPF)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $950M. Against analyst estimates the company has EPS beat 1 of 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter (converted from EUR)
PeriodRevenueNet incomeEPS
Q2 FY2026$950M$32M$1.73 (diluted)
Q1 FY2026$852M$13M$0.69 (diluted)
Q4 FY2025$1.28B$106M$5.67 (diluted)
Q3 FY2025$937M$40M$2.14 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Drägerwerk AG & Co. KGaA (DGWPF)?

Short answer

The distress and quality screens read Altman Z 3.03 · Piotroski F 8. Trailing ratios: ROE 9.8% · ROA 4.8% · current ratio 2.07 · earnings yield 9.9% · free-cash-flow yield 10.4%.

What has been published about Drägerwerk AG & Co. KGaA (DGWPF)?

Read these with our analysis →

Common Questions About DGWPF

These answers are editorial: 2 of these 8 answers are drawn from the DGWPF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 6 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is DGWPF a good stock to buy?

Stock Expert AI does not rate DGWPF buy, sell or hold. Drägerwerk AG & Co. KGaA has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the DGWPF stock price today?

The last price recorded on this page for Drägerwerk AG & Co. KGaA (DGWPF) is $102.31, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What are the implications of Drägerwerk AG & Co. KGaA's OTC listing for investors?

Drägerwerk AG & Co. KGaA's listing on the OTC market, particularly in the 'OTC Other' tier with an 'Unknown' disclosure status, carries several implications for investors.

What are the main risks for DGWPF?

The primary risks for DGWPF stem from its dual market exposure and OTC listing. A significant risk is the cyclical nature of government and hospital spending, which directly impacts demand for its medical devices. Economic downturns or budget constraints in healthcare sectors globally could lead to reduced sales.

What are the key factors to evaluate for DGWPF?

Evaluate DGWPF on fundamentals, analyst consensus, and risk factors. P/E: 12.80x. Not financial advice.

How frequently does DGWPF data refresh on this page?

DGWPF's price is the last quote we recorded, from the Oct 5, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven DGWPF's recent stock price performance?

Drägerwerk AG & Co. KGaA (DGWPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing global presence and strong brand recognition in both medical and safety technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider DGWPF overvalued or undervalued right now?

Drägerwerk AG & Co. KGaA (DGWPF) trades at 12.80x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources — records for every figure on this page (15 figures)

The 15 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

FMP — 9 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$102.31FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T18:24:40.701Z.
px.changeChange on the day0.00%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$1.92BFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-05T18:24:39.729Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars$0.00FMPFinancial Modeling Prep (FMP) · quote
px.pePrice / earnings (trailing)12.80FMPFinancial Modeling Prep (FMP) · quote
px.volumeShares traded on the day100FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q2 FY2026$950MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_incomeNet income, Q2 FY2026$32MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_tableQuarterly income statement4 quarters through Q2 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed

UNRECORDED — 6 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.range5252-week range$57.00 – $102.31UNRECORDEDStored company-profile observation — Captured 2026-09-30
id.employeesEmployees16,687UNRECORDEDStored company-profile observation — Captured 2026-09-30
id.ceoChief executiveStefan A. DragerUNRECORDEDStored company-profile observation — Captured 2026-09-30
earn.historyReported versus estimated, recent quartersEPS beat 1 of 8UNRECORDEDStored earnings-history observation — Captured 2026-09-30 · Expired observation
fin.scoresDistress and quality screensAltman Z 3.03 · Piotroski F 8UNRECORDEDStored financial-scores observation — Captured 2026-10-04 · Expired observation
fin.ratiosReturn and yield ratios (trailing twelve months)ROE 9.8% · ROA 4.8% · current ratio 2.07 · earnings yield 9.9% · free-cash-flow yield 10.4%—UNRECORDEDStored key metrics — Date unknown
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.